← Back to directory

Judd W. Moul

Researcher Next ID · RN-025972

Researcher · Medicine

Duke University

Durham, Greece

Not currently recruitingFunding unknown
Works count
814
Citation count
28,033
H-index
88
i10-index
366

Research interests

Medicine
Prostate Cancer Diagnosis and Treatment
Prostate Cancer Treatment and Research
Urologic and reproductive health conditions
Hormonal and reproductive studies
Testicular diseases and treatments

Publications

  • Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017

    Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.74.1173

  • Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

    Journal of Clinical Oncology · 2014 · 10.1200/jco.2013.52.3696

  • A Critical Analysis of the Long-Term Impact of Radical Prostatectomy on Cancer Control and Function Outcomes

    European Urology · 2011 · 10.1016/j.eururo.2011.11.053

  • Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology

    British Journal of Urology · 2010 · https://doi.org/10.1111/j.1464-410x.2010.09334.x

  • Satisfaction and Regret after Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy

    European Urology · 2008 · 10.1016/j.eururo.2008.06.063

  • Early Versus Delayed Hormonal Therapy for Prostate Specific Antigen Only Recurrence of Prostate Cancer After Radical Prostatectomy

    The Journal of Urology · 2008 · 10.1016/j.juro.2008.03.138

  • Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

    The Journal of Urology · 2007 · https://doi.org/10.1016/j.juro.2006.10.097

  • Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

    The Journal of Urology · 2007 · https://doi.org/10.1016/j.juro.2007.03.003

  • Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer

    JAMA · 2007 · 10.1001/jama.298.19.2275

  • The Changing Face of Prostate Cancer

    Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.02.9751

  • Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

    Oncogene · 2005 · 10.1038/sj.onc.1208518

  • Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients

    Oncogene · 2004 · 10.1038/sj.onc.1207069

  • Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility

    Clinical Chemistry · 2004 · 10.1373/clinchem.2004.038950

  • Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy

    Urology · 2003 · 10.1016/s0090-4295(02)02411-1

  • Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy

    Journal of Clinical Oncology · 2003 · 10.1200/jco.2004.03.132

  • Surrogate End Point for Prostate Cancer-Specific Mortality After Radical Prostatectomy or Radiation Therapy

    JNCI Journal of the National Cancer Institute · 2003 · 10.1093/jnci/djg043

  • Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy

    The Journal of Urology · 2003 · 10.1097/01.ju.0000062674.43964.d0

  • Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era

    Journal of Clinical Oncology · 2003 · 10.1200/jco.2003.01.075

  • PCGEM1 , a prostate-specific gene, is overexpressed in prostate cancer

    Proceedings of the National Academy of Sciences · 2000 · 10.1073/pnas.97.22.12216

  • PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCER

    The Journal of Urology · 2000 · 10.1016/s0022-5347(05)67511-8

  • p53 Regulates the Expression of the Tumor Suppressor Gene Maspin

    Journal of Biological Chemistry · 2000 · 10.1074/jbc.275.9.6051

  • MULTICENTER PATIENT SELF-REPORTING QUESTIONNAIRE ON IMPOTENCE, INCONTINENCE AND STRICTURE AFTER RADICAL PROSTATECTOMY

    The Journal of Urology · 2000 · 10.1016/s0022-5347(05)67819-6

  • Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men

    New England Journal of Medicine · 1996 · 10.1056/nejm199608013350502

  • Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer

    The Journal of Urology · 1996 · 10.1016/s0022-5347(01)65641-6

  • Prostate-Specific Antigen Values at the Time of Prostate Cancer Diagnosis in African-American Men

    JAMA · 1995 · 10.1001/jama.1995.03530160029029

  • Radical Prostatectomy for Clinical Stage T1-2N0M0 Prostatic Adenocarcinoma: Long-Term Results

    The Journal of Urology · 1990 · 10.1016/s0022-5347(17)39686-6

Current projects

    No projects listed.